Definitive Healthcare (NASDAQ:DH) Stock Rating Upgraded by Wall Street Zen

Definitive Healthcare (NASDAQ:DH) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

DH has been the topic of a number of other reports. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a report on Wednesday, January 21st. Zacks Research downgraded shares of Definitive Healthcare from a “hold” rating to a “strong sell” rating in a report on Thursday, March 5th. Canaccord Genuity Group cut their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Friday, February 27th. Barclays reduced their price objective on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research note on Monday, December 8th. Finally, Stephens lowered their target price on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a research note on Friday, February 27th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $3.52.

Definitive Healthcare Price Performance

DH opened at $1.13 on Friday. The firm has a market cap of $159.74 million, a P/E ratio of -0.90 and a beta of 1.66. The business’s fifty day simple moving average is $1.89 and its 200 day simple moving average is $2.67. Definitive Healthcare has a 52 week low of $1.07 and a 52 week high of $4.70. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.41.

Institutional Investors Weigh In On Definitive Healthcare

Several large investors have recently made changes to their positions in DH. Invesco Ltd. raised its stake in shares of Definitive Healthcare by 5.8% in the 4th quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock valued at $337,000 after acquiring an additional 6,400 shares during the period. XTX Topco Ltd boosted its position in Definitive Healthcare by 57.5% during the 4th quarter. XTX Topco Ltd now owns 75,306 shares of the company’s stock worth $216,000 after purchasing an additional 27,495 shares during the period. Occudo Quantitative Strategies LP purchased a new stake in Definitive Healthcare during the 4th quarter worth $95,000. Millennium Management LLC increased its holdings in Definitive Healthcare by 230.9% in the 4th quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock valued at $953,000 after purchasing an additional 231,743 shares in the last quarter. Finally, Inspire Investing LLC increased its holdings in Definitive Healthcare by 505.7% in the 4th quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock valued at $2,006,000 after purchasing an additional 583,562 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.